There is increasing evidence that hyperlipidemia refers to an imbalance in the lysozyme spectrum; for example, it has been reported that LysoPC (22:6) and LysoPC (20:4) were significantly reduced in mice fed a high-fat diet for 4 weeks whereas, in atherosclerotic rabbits, LysoPC (16:1), LysoPC (16:1), and LysoPC (20:5) levels were elevated. Here, LYZ is linked to hyperlipidemia.